fda compounding semaglutide enforcement october 2025 news New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Congress Introduces SAFE Drugs Act

The addition of Cagrilintide to your laboratory protocols allows for deep-dive analysis of metabolic pathways and cellular aging simulations

Many individuals who start taking GLP-1s do experience weight loss

What is glutathione?Glutathione is a molecule composed of three amino acids (glutamine, cysteine, glycine)

Studies examining colon-colon anastomoses and colocutaneous fistulas demonstrate enhanced healing with BPC-157 treatment, suggesting applications in post-surgical recovery and inflammatory conditions

Unlike current treatments for obesity that primarily focus on a single mechanism, Retatrutide acts on multiple receptors simultaneously, which may enhance its effectiveness in reducing body weight

It is the most effective form of carnitine